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Virus growth modulationse virus (FMDV) 3A protein is involved in virulence and host range. A
distinguishing feature of FMDV 3B among picornaviruses is that three non-identical copies are encoded in
the viral RNA and required for optimal replication in cell culture. Here, we have studied the involvement of
the 3AB region on viral infection using constitutive and transient expression systems. BHK-21 stably
transformed clones expressed low levels of FMDV 3A or 3A(B) proteins in the cell cytoplasm. Transformed
cells stably expressing these proteins did not exhibit inner cellular rearrangements detectable by electron
microscope analysis. Upon FMDV infection, clones expressing either 3A alone or 3A(B) proteins showed a
signiﬁcant increase in the percentage of infected cells, the number of plaque forming units and the virus
yield. The 3A-enhancing effect was speciﬁc for FMDV as no increase in viral multiplication was observed in
transformed clones infected with another picornavirus, encephalomyocarditis virus, or the negative-strand
RNA virus vesicular stomatitis virus. A potential role of 3A protein in viral RNA translation was discarded by
the lack of effect on FMDV IRES-dependent translation. Increased viral susceptibility was not caused by a
released factor; neither the supernatant of transformed clones nor the addition of puriﬁed 3A protein to the
infection medium was responsible for this effect. Unlike stable expression, high levels of 3A or 3A(B) protein
transient expression led to unspeciﬁc inhibition of viral infection. Therefore, the effect observed on viral
yield, which inversely correlated with the intracellular levels of 3A protein, suggests a transacting role
operating on the FMDV multiplication cycle.
© 2008 Elsevier Inc. All rights reserved.Introduction
Foot-and-mouth disease virus (FMDV) is the prototypic member of
the aphthovirus genus within the family Picornaviridae (Bachrach,
1977; Domingo et al., 1990; Pereira, 1981; Sobrino et al., 2001) and the
etiological agent of a devastating disease of livestock (Knowles et al.,
2001). The viral particle is composed by a protein capsid that contains
a positive-sense RNA molecule of about 8500 nucleotides that is
infectious and encodes a single polyprotein, processed in infected cells
to yield different polypeptide precursors and themature viral proteins
(Belsham, 2005; Sobrino et al., 2001). Polyprotein processing is carried
out by cis and trans-acting viral proteases rendering the mature
structural and nonstructural (NS) proteins (Ryan and Drew, 1994). The
proteins encoded within the P1 region (VP1-4) form the capsid, while.
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l rights reserved.L protein and those encoded in the P2 (2B,2C) and P3 (3A, 3B, 3C and
3D) regions are NS proteins (Belsham and Martínez-Salas, 2004).
Picornavirus NS proteins, and some of their precursors, are
involved in crucial aspects of viral cycle, such as RNA replication,
rearrangements of intracellular membranes required for this process,
pathogenesis and lysis of host cells (Andino et al., 1999; Bienz et al.,
1983; Buenz and Howe, 2006; Cho et al., 1994; Choe et al. 2005;
Whitton et al., 2005). Protein 3A is an example of this multifunctional
role. In poliovirus (PV), the interaction between the RNA replication
complex and intracellular membranes appears to be accomplished by
proteins 3A and 2C, which have membrane-binding properties (Bienz
et al., 1987; Semler et al., 1982). When expressed independently PV 3A
co-fractionates with ER markers (Suhy et al., 2000) and its single
transient expression can disrupt the secretory apparatus (Choe et al.,
2005; Deitz et al., 2000; Doedens et al., 1997). On the other hand, 3AB
presumably anchors 3B in the novo intracellular membranes
originated during the initiation of RNA replication, where uridylylated
3B primes the synthesis of nascent viral RNAs (Andino et al., 1993;
Lama et al., 1994; Lyle et al., 2002; Takegami et al., 1983; Towner et al.,
1996). PV 3AB has a non-speciﬁc RNA-binding activity and associates
Table 1
Selection of BHK-21 clones stably expressing 3A or 3A(B) FMDV proteins and its effect
on cell growth
Plasmid PurRa Colony
size b
Growth
Capacity(%) c
Transcript
detection (%) d
None (mock) 0/0 - - -
pPur 57/76 L 98 0 (8)
pRSV/L 51/75 L/M 92 0 (8)
pRSV/3A 33/64 M/S 62 82 (14)
pRSV/3AB1 24/35 S/M 48 53 (10)
PRSV/3AB1B2B3 27/29 M/L 58 67 (17)
a Number of cell clones visualized by crystal violet staining after 12 days of seeding at
a 1:10 dilution of the initially co-transfected cells on a 100mmØ dish. The results of two
independent experiments are presented.
b Average size of PurR clones: L, large (1.5-3 mm); M, medium (1-1.5 mm); S, small
(0.5-1 mm). The ﬁrst letter indicates the predominant colony size.
c Percentage of clones that were efﬁciently expanded to yield a monolayer of 4-
6×106cells on a 60 mm Ø dish.
d Percentage of viable clones yielding positive RT-PCR ampliﬁcation of the
corresponding FMDV transcript. The number of clones positive for RT-PCR is
indicated in brackets.
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3CD precursor to form a ribonucleoprotein complex required for PV
RNA synthesis (Hope et al., 1997; Lama et al., 1994; Xiang et al., 1998;
Xiang et al., 1995). Additionally, 3AB has been reported as a co-factor
for 3Dpol activity (Lama et al., 1995).
The organization of the FMDV 3AB region is unique among the
picornaviruses. Protein 3A extends its carboxy-terminus in at least 60
amino acids, a feature recently reported for bovine rhinovirus type 2
(Hollister et al., 2008). Also, three non-identical copies of 3B
(3AB1B2B3) are encoded and expressed in susceptible cells (Falk et
al., 1992; Forss et al., 1984; Garcia-Briones et al., 2006; O'Donnell et al.,
2001). Each of the 3B proteins can be in vitro uridylylated by 3Dpol
(Ferrer-Orta et al., 2006; Nayak et al., 2005) and deletions of
redundant copies led to a decrease in FMDV replication efﬁciency in
cell culture (Falk et al., 1992) and attenuation in pigs (Pacheco et al.,
2003). Engineered FMDV RNA with truncated 3A versions showed a
decreased infectivity in bovine, but not in BHK-21 or porcine cells
(Pacheco et al., 2003). Mutations in 3A, found in ﬁeld isolates, are
associated to FMDV hypervirulence in pigs and attenuation in cattle
(Beard and Mason, 2000), and a single amino acid substitution in this
protein can mediate adaptation of the virus to guinea-pigs (Nunez et
al., 2001).
In comparison to other picornaviruses, differences in FMDV-
induced membrane rearrangements in infected cells have been
reported. FMDV infection is resistant to brefeldin A treatment
(O'Donnell et al., 2001), a drug that disrupts the Golgi complex and
inhibits replication of other picornaviruses, such as PV (Irurzun et al.,
1992). In PV and coxackievirus, 3A, but not 3AB, mediates the
inhibition of the anterograde trafﬁc between the ER and the Golgi
(Doedens et al., 1997), resulting in a reduced secretion of proteins such
as MHC class I molecules (Choe et al., 2005) and TNF receptor
(Neznanov et al., 2001). In FMDV, transient expression of 2BC, but not
of 3A, has been reported to inhibit host protein secretion in Vero cells
(Moffat et al., 2005).
FMDV 3A protein is predicted to contain a hydrophobic domain
(Forss et al., 1984) and is found associated to crudemembrane extracts
from infected cells (Moffat et al., 2005). Fluorescence to 3A in infected
cells partially co-localizes with the ERmarker calreticulin andwith the
Golgi stacks protein p58 (Garcia-Briones et al., 2006; O'Donnell et al.,
2001). Unlike what is observed in other picornaviruses, transient
expression of 3AB proteins does not induce major rearrangements of
intracellular membranes as inferred from immunoﬂuorescence and
electron microscopy (EM) studies (Garcia-Briones et al., 2006;
O'Donnell et al., 2001). When transiently expressed, FMDV 3A
preferentially localized at small vesicles (Moffat et al., 2005; O'Donnell
et al., 2001). Interestingly, sequential addition of protein 3B copies
resulted in a relocation of the 3AB products − hence 3A(B) − that
became progressively compact and ﬁbrous (Garcia-Briones et al.,
2006). On the other hand, FMDV precursor 3AB1B2B3C has been
proposed to facilitate the transport of viral protease 3C to the nucleus
in infected cells (Capozzo et al., 2002).
Cells transiently expressing PV membrane-binding proteins,
including 3A, showed a markedly reduced ability to support PV
replication as a consequence of the modiﬁcation of ER membranes,
suggesting that a functional replication complex is formed in cis, in a
coupled process involving viral translation, membrane modiﬁcation
and viral RNA synthesis (Egger et al., 2000). To investigate the
functional role of the FMDV proteins encoded in the 3AB region, we
have generated BHK-21 transformed cells that stably express 3A
protein, or the precursors 3AB1 and 3AB1B2B3. The level of expression
of 3A found in these cells was low, and no detectable cell alterations
were observed in the clones analyzed by electron microscope.
Interestingly, 3A clones produced higher viral titers upon FMDV
infection. This effect was also observed in 3AB1 and 3AB1B2B3 clones,
suggesting that expression of proteins from the 3AB region can
speciﬁcally enhance viral replication. This stimulation was speciﬁc forFMDV as it was not observed upon infection with encephalomyocar-
ditis virus (EMCV) or vesicular stomatitis virus (VSV). In contrast, a
decrease in FMDV, EMCV and VSV multiplication was observed in
BHK-21 cells transiently expressing higher levels of these proteins.
Thus, while low levels of expression of 3AB proteins resulted in a
speciﬁc increase of FMDV multiplication, an unspeciﬁc effect was
found in cells transiently expressing higher levels of these proteins, in
which a decrease of FMDV, EMCV and VSV yield was observed.
Results
Selection of BHK-21 clones stably expressing 3A, 3AB1 or 3AB1B2B3
proteins
To investigate the effect of 3A or 3A(B) proteins on FMDV
multiplication cycle, we derived BHK-21 cell clones stably expres-
sing 3A alone or as fusion protein with one or three copies of FMDV
3B. To this end, plasmid pPur alone or in combination with pRSV
derivatives expressing 3A, 3AB1 or 3AB1B2B3 from C-S8c1 FMDV,
was transfected into BHK-21 cells and used for selection of stable
transfectants, resistant to puromycin (PurR). The effect of transgene
expression on cell survival was estimated from the number and size
(diameter) of PurR clones that expressed the corresponding FMDV
transcript (Table 1). Relative to the results obtained with cells
transfected with pPur (Pur clones) alone or in combination with
pRSV/L (Luc clones), a lower number of clones was recovered in two
independent experiments in co-transfections with plasmids expres-
sing the FMDV transcripts. The percentage of clones that could be
expanded to obtain conﬂuent monolayers was also reduced.
Transcription of FMDV speciﬁc RNAs in the expanded clones was
ﬁrst monitored by RT-PCR ampliﬁcation of cytoplasmic RNA, and
later conﬁrmed by nucleotide sequencing at passage 8th. The
percentage of viable clones that showed detectable levels of the
speciﬁc FMDV RNA ranged from 82% (3A) to 53% (3AB1) (Table 1).
The growth rate of 3A(B) clones was not noticeably different from
that of the control Pur and Luc clones.
Expression of FMDV proteins, estimated by western blotting, was
detected in the clones positive for FMDV RNA (representative
examples are shown in Fig. 1A). The level of protein expression in
the different clones was, in all cases, signiﬁcantly lower than that
observed in transfected cells transiently expressing these proteins
from pRSV derivatives (see Materials and Methods), as conﬁrmed by
the quantiﬁcation of the intensity of the 3A-speciﬁc bands (Fig. 1A),
suggesting that high levels of expression of proteins from the 3AB
region could be detrimental for cell viability. Additional faint bands of
a size corresponding to various 3AB products were observed, as
Fig. 1. Speciﬁc expression of FMDV proteins. (A) Western blot detection of 3A protein, using MAb 2C2, in transformed clones or in BHK-21 cells transiently expressing 3AB proteins.
Pur104 and Luc207 correspond to two different negative controls, stably expressing only puromycin resistance or puromycin and luciferase, respectively. For transient expression,
BHK-21 cells were processed at 24 h pt with the pRSV derivatives expressing the proteins indicated. In each case, the expression levels (intensity of the 3A/3A(B) protein band)
given as percentage of that of clone 3A242, is indicated at the bottom of each line. Immunoblotting of β-actin was included as control of protein loading. (B) Representative
microscope images of the distribution of 3A ﬂuorescence in clones stably expressing 3A/3A(B) proteins. Cells were processed for immunoﬂuorescence staining using MAb 2C2 (Bar:
20 μm). (C) Electron microscopy images of BHK-21 cells and clones stably expressing 3A242 and 3AB1B2B3209. Endo-membrane systems corresponding to endoplasmic reticulum
(ER) and the Golgi apparatus (G) are indicated. Arrows point to residual vesicles accumulated in clone 3AB1B2B3209. Bar: 0.2 μm.
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bands, which could result from cleavage by cellular proteases, was
conﬁrmed in transfected cells transiently expressing the 3AB
products, by immunobloting with MAb 1F8 targeted to 3B (data not
shown). The amount of these proteins in the transformed cells was
below the detection level of this antibody.
Stable expression of proteins from the 3AB region does not induce major
cell rearrangements
FMDV 3A protein associates to membrane extracts from infected
cells (Moffat et al., 2005), in which alterations of endomembranes,
including the formation of vesicles of an unclear origin, have been
reported (Garcia-Briones et al., 2006; Knox et al., 2005; Monaghan et
al., 2004). To investigate whether expression of 3A or 3A(B) proteins
induced alterations in cell membrane structures, we ﬁrst performed
immunoﬂuorescence analysis. As shown in Fig. 1B, cells expressing
proteins of the 3A region showed positive reaction in the cytoplasmwith the speciﬁc anti-3A antibody, with a perinuclear distribution.
Second, the EM images of negative stained cells from clones 3A242
and 3AB1B2B3209 revealed no major changes in the endomembrane
systemwhen compared to control BHK-21 cells, in which the integrity
of the ER and the Golgi was maintained. The analysis of 3AB1B2B3209
cells showed an accumulation of lysosomes and residual vesicles that
could suggest alterations in the degradative pathways (Fig. 1C).
Thus, no gross alterations of BHK-21 cell structures, including
endomembranes as those observed during FMDV infection, were
found in cells stably expressing 3A or 3A(B) proteins.
FMDV multiplication is speciﬁcally increased in cells expressing 3A, 3AB1
or 3AB1B2B3 proteins
To address the effect of the stable expression of proteins from the
3AB region on the FMDV multiplication cycle, we ﬁrst analyzed virus
plaque formation. To this end, monolayers of clones expressing these
proteins were infected with FMDV isolate C-S8c1 (50 PFU) and the
37M.F. Rosas et al. / Virology 380 (2008) 34–45virus plaques developed after 24 h were scored. In general, an increase
was observed in the PFU recovered from monolayers expressing 3A or
3A(B) proteins. The percentages of PFU increase (PI) observed in each
of the 36 clones expressing 3A, 3AB1 or 3AB1B2B3, relative to the PFU
scored in the control Pur clones (average from 4 clones) –which wereFig. 2. Effect on virus plaque formation of the stable expression of FMDV 3AB proteins. (A) Fr
3AB1 or 3AB1B2B3. PI values are represented against the number of clones analyzed that survi
50 PFU of FMDV and the virus plaques developed were scored at 24 h pi. PI values were calcul
cases. The PI values for the clones analyzed in Fig. 1A were: 3A242 (207), 3A244 (120), 3AB11
3AB1B2B3217 (146). (B) Representative examples of FMDV PFU recovered in clones expressin
recovered after infectionwith about 100 PFU / monolayer of VSV, EMCV or FMDV in clones ex
with clone Luc207 are included. The means and SD from three independent experiments are
with about 100 PFU of each virus in clones expressing 3A/3A(B) proteins (plaque counts areundistinguishable from those of a duplicate of BHK-21 cells infected in
parallel (data not shown) – are summarized in Fig. 2A. Four additional
control Luc clones gave PI ranging from 0 to 7%, supporting a lack of
effect of the clonal selection on FMDV susceptibility. Except for ﬁve
clones whose PI ranged from 10-50, the PFU values in the remainingequency distribution of PFU increase (PI) upon infection of clones stably expressing 3A,
ved puromycin selection in each group. Conﬂuent monolayers were infected with about
ated relative to the PFU recovered in the control Luc clones. SD was lower than 15% in all
01 (90), 3AB1201 (102), 3AB1B2B3104 (27), 3AB1B2B3207 (234), 3AB1B2B3209 (300) and
g 3A/3A(B) proteins (plaque counts are given in parenthesis). (C) The percentage of PFU
pressing 3A/3A(B) proteins, relative to those recovered in the control Pur clones. Results
shown. (D) Representative examples of VSV or EMCV plaques, recovered upon infection
given in parenthesis).
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multiple comparisons, p≤0.05) than those of the control clones. The
highest PI frequency was found for clones expressing 3AB1B2B3. An
inverse correlation between the amount of FMDV protein detected in
individual clones and the corresponding PI values was noticed (Fig. 1A
and legend of Fig. 2A). Thus, clone 3AB1B2B3104, which showed a high
level of 3AB1B2B3 expression, induced a low (27%) PI while clone
3AB1B2B3209, which showed a low expression level, exhibited one of
the highest (300%) PI observed.
The speciﬁcity for FMDV of this increase in PFU was conﬁrmed for
clones 3A242, 3AB1201 and 3AB1B2B3209. When monolayers of these
clones were infected with VSV, an unrelated rhabdovirus, or with the
picornavirus EMCV, the number of plaques and their sizewas similar to
those developed by the infected control clones, Luc207 (Fig. 2C and D)
and Pur104 (data not shown). Thus, stable expression of the protein 3A
speciﬁcally enhanced FMDV plaque formation in BHK-21 clones. This
speciﬁc effect was also observed when the protein 3Awas fused to 3B.
To further address the effect on the viral growth of the stable
expression of proteins from the 3AB region, the virus titers recovered
upon FMDV C-S8c1 infection of clones expressing 3A and 3AB1B2B3
were used to estimate the increase in viral yield, compared with the
titers recovered from 4 independent Pur and Luc control clones. While
no major morphological differences were observed in 3A(B)-infected
clones relative to infected control clones, an advanced CPE (about 1
hour) was noticed by light microscopy. No signiﬁcant differences were
found in the virus titers recovered from control clones, which were
undistinguishable from those of a duplicate of BHK-21 infected in
parallel (data not shown). As shown in Fig. 3A, the highest titer
increases were observed at 4 h pi, with differences up to ten-fold
relative to the mean of control clones that, in all cases, were
statistically signiﬁcant, being the level of signiﬁcance lower for clones
expressing higher amounts of FMDV protein (i.e. clones 3A244 orFig. 3. FMDV yield in infected clones expressing 3AB proteins. (A) Time course of FMDV produ
Themeans and SD from three independent experiments are shown. (B) Signiﬁcance (p values
among the mean of control clones and each of the 3A(B)-expressing clones analyzed.3AB1B2B3104) (Fig. 3B). This increase was also observed at later
infection times to a lesser extent at 8 h pi, including 18 and 24 h pi,
when cells had developed extensive cytopathic effect. Infected clones
expressing 3AB1B2B3 showed, in average, higher titer increases (Fig. 3),
being 3AB1B2B3209 the highest. These results were in agreement with
those obtained in the PFU assay (see Fig. 2A). Again, the virus
production exhibited by clones 3AB1B2B3104 and 3AB1B2B3209
correlated inversely with the expression level of the corresponding
FMDV proteins (Fig. 1A).
To assess whether the increase in PFU recovery and virus yield
correlated with the level of detection of FMDV capsid proteins,
extracts from infected monolayers of 3A or 3AB1B2B3 clones were
analyzed by western blot, using a MAb targeted to the capsid protein
VP1. As shown in Fig. 4A, relative to the control Pur104, clones 3A242
and 3AB1B2B3209 showed higher intracellular levels of VP1 at the
different times post infection analyzed. Likewise, an increase in the
percentage of cells positive for VP1 detection by immunoﬂuorescence
was observed from 2 h pi. in monolayers infected with FMDV (Fig. 4B).
This increase in the percentage of infected cells was speciﬁc for FMDV,
as it was not detected in cells infected with VSV (data not shown).
The enhancement of proteins 3A or 3AB1B2B3 on viral yield is not due to a
factor released to the growth medium
To address whether 3A and 3A(B) proteins were released from cells
to the supernatant, facilitating subsequent infection events, we ﬁrst
analyzed the presence of FMDV 3A in the supernatant of transformed
cell monolayers. To this end, supernatant aliquots (corresponding to
about 2x107 cells) were dialysed and then concentrated. To control
protein stability in the concentration steps, immunoblotting of Pur104
supernatant supplemented with crude protein extracts from 3A or
3AB1B2B3 clones (containing about 40 μg) was included in parallel. Thection in clones infected at a MOI of about 1. Four Luc and Pur control clones are included.
, obtained with the Student's t test for multiple comparisons) of the differences, at 4 h pi,
Fig. 4. Expression of VP1 capsid protein in FMDV infected 3A and 3A(B) clones. (A)
Detection of VP1 protein in cell extracts collected at different h pi (MOI of about 1) by
western blotting using MAb SD6. Immunoblotting of β-actin was included as control of
protein loading. (B) Percentage of cells expressing VP1 at different h pi (MOI of about 10)
detected by ﬂuorescence. The means and SD from two independent experiments are
presented.
Fig. 5. Analysis of the release of 3AB proteins from FMDV clones. Effect on FMDV growth
and IRES-dependent expression. (A) Analysis of FMDV 3A/3A(B) release to the cell
supernatant. Western blot detection of 3A protein, using MAb 2C2, in concentrated
supernatants of 2×107 cells stably expressing the indicated proteins. As a control of
protein stability in the concentration steps, blotting of Pur104 supernatant supple-
mented with the indicated clone extracts containing FMDV 3A or 3AB1B2B3 protein
(about 40 μg) was included. (B) Effect of puriﬁed FMDV 3A protein addition to the
supernatant on virus yield. BHK-21 cells (about 2×106 cells, 35 mm Ø plate) grown in
the presence or absence of the indicated amount of puriﬁed FMDV 3A protein were
infected with FMDV (about 100 PFU/monolayer). The PFU developed were scored at
24 h pi and PI values were calculated relative to the PFU recovered in BHK-21 grown in
absence of puriﬁed 3A protein. (C) Effect of FMDV 3A/3A(B) protein expression on FMDV
IRES-dependent translation efﬁciency. IRES-dependent translation was estimated as
luciferase activity normalized to CAT activity, measured in extracts from 3A or 3AB1B2B3
clones transfected with CMVpBIC bicistronic plasmid, relative to the value obtained in
Pur104 transfected clones. The results were expressed in arbitrary units, error bars
correspond to the SEM from two duplicated experiments.
39M.F. Rosas et al. / Virology 380 (2008) 34–45results, shown in Fig. 5A, indicated that 3A was not secreted to the
supernatant in amounts above 4 μg/2×107 cells, which was the lower
limit of detection in this experimental approach. A similar analysis in
BHK-21 cells transiently expressing high amounts of 3A or 3AB1B2B3
proteins was also negative (data not shown).
To further analyze the possibility that small amounts of 3A protein,
below the detection level of western blotting, were exerting a
functional role on subsequent virus infection, we determined the %
of virus yield in BHK-21 cells growing in the presence of puriﬁed
FMDV 3A protein. The results indicated that addition of a wide range
of 3A (4 to 100 μg) to growing cell monolayers did not modify
production of FMDV plaques (Fig. 5B). Likewise, addition of super-
natant from cells transiently expressing 3A or 3AB1B2B3 proteins to
BHK-21 monolayers did not modify virus yield (data not show).
Stable expression of 3A or 3AB1B2B3 proteins does not stimulate FMDV
IRES-dependent translation
To determine whether the increase of FMDV yield described above
resulted from an effect on IRES-driven translation, the earliest
intracellular event during picornavirus gene expression (Belsham
and Martínez-Salas, 2004), clones expressing 3A or 3AB1B2B3 proteins
were used to assay FMDV IRES-dependent translation efﬁciency. As
shown in Fig. 5C, no stimulation of internal initiation was observed in
clones expressing 3A or 3AB1B2B3 proteins, relative to control clones.
This result was in agreement with previous reports on the effect of PV
3A protein mutations that caused defective viral RNA synthesis,producing small plaques without modiﬁcation of translation and
polyprotein processing in cell-free systems.
Transient expression of proteins from the 3AB region induces a decrease
of FMDV, EMCV and VSV multiplication
PV 3A transient expression has been shown to result in a markedly
reduced abilityofHeLacells to support PV replication (Egger et al., 2000).
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proteins could lead to different effects during transient expression, pRSV
derivatives expressing 3A,3AB1 or 3AB1B2B3,were transfected inBHK-21
cells. The levels of protein expression estimated by western blottingFig. 6. Effect of transient expression of 3AB proteins on FMDV and VSVmultiplication in BHK-
infected with FMDV (MOI of about 1). BHK-21 cells transfected with PRSV/L were included a
four proteins from the 3AB region was signiﬁcantly lower than that of control cells (p≤0.001
about 100 PFU/monolayer of the indicated virus, were grown in the presence of agar. The
recovered in cells transfected with PRSV/L. Non-transfected BHK-21 cells were included as co
in parenthesis). (C) VSV plaque formation. Cells were infectedwith VSV and processed as in (B
counts are given in parenthesis).were higher than those observed in stable expression (Fig.1A), being the
highest levels detected at 18 to 24 h pt (data not shown). These high
protein levels induced a detrimental effect in BHK-21 cells, as indicated
by a 20 to 30 % reduction in cell viability at 24 h pt (data not shown).21 cells. (A) Time course of FMDV titers recovered in the supernatants of transfected cells
s control. The differences in virus titer observed at 4 h pi in cells expressing each of the
). (B) FMDV and EMCV plaque formation in transfected cells. Monolayers, infected with
PFU developed were scored at 24 h pi. PR values were calculated relative to the PFU
ntrol. Representative examples of the PFU recovered are shown (plaque counts are given
). In all cases, themeans and SD from three independent experiments are shown (plaque
41M.F. Rosas et al. / Virology 380 (2008) 34–45When BHK-21 cells transfected with pRSV/L were infected (at 16 h
pt) with C-S8c1 FMDV, the viral titers in culture medium were
undistinguishable from those found in mock-transfected cells, at any
time-points analyzed (data not shown). Conversely, a reduction in the
virus yield, relative to cells transfected with pRSV/L, was observed in
cells transiently expressing FMDV 3A or 3A(B) proteins (Fig. 6A) at the
different infection times. The virus titers were slightly lower in cells
expressing 3AB1 and 3AB1B2B3 than in those expressing 3A and
3AB1B2 (Fig. 6A). Similar reductions were observed in the capacity to
produce FMDV plaques. In these assays, cells transiently expressing
3AB1 and 3AB1B2B3 exhibited the higher plaque reduction (PR) values,
and no signiﬁcant difference in the plaque size was observed (Fig. 6B).
Similar results were obtainedwith 3A and 3A(B) transfected IBRS cells,
a porcine line (data not shown). The magnitude of virus titer decrease
was slightly lower than the virus titer increase observed in infected
3A/3A (B) clones.
The inhibition of the virus multiplication was not speciﬁc for
FMDV, as indicated by the PR observed upon EMCV (Fig. 6B) and
VSV (Fig. 6C) infection. In the VSV case, cells expressing 3AB1B2B3
showed the higher PR value, which was similar (17%) to that found
for FMDV (Fig. 6C). Thus, in contrast to what observed in clones
stably expressing proteins from the 3AB region, transient expres-
sion of 3A, 3AB1, 3AB1B2 and 3AB1B2B3 results in a reduction of the
FMDV yield and plaque formation in BHK-21 cells. This inhibitory
effect extends also to the picornavirus EMCV and the RNA virusFig. 7. Correlation between transient expression of 3A/3A(B) proteins and infection of
single BHK-21 cells. Transfected monolayers, including those with pRSV/L (Luc), were
infected (at 16 h pt) with FMDV or VSV (MOI of about 10). Non-transfected BHK-21 cells
were included as control. After 4 h, the percentage of cells expressing 3A, VP1 (for FMDV
infection) or G protein (for VSV infection) was monitored, using polyclonal serum 163
and MAb SD6 or I1, respectively. (A) Percentage of cells expressing VP1 (FMDV) or G
(VSV) proteins. (B) Percentage of VSV infected cells expressing 3A, G or both proteins. In
A and B, the mean and SD from two independent experiments (about 1000 cells were
scored in each of them), are presented.
Fig. 8. Dose-effect inhibition of FMDV growth by transient expression of 3AB1B2B3. (A)
Modulation of 3AB1B2B3 transient expression. Western blot detection of 3A protein,
using MAb 2C2, in cell monolayers at 24 h post transfection with different ratios of
pRSV/3AB1B2B3 : pRSV/L. The expression level (intensity of the 3AB1B2B3 protein band)
given as percentage of that of cells transfected with pRSV/3AB1B2B3 alone (1:0) is
indicated at the bottom of each line. Immunoblotting of β-actin was included as control
of protein loading. (B) FMDV plaque formation. Transfected cells, as in A, were infected
with about 100 PFU/monolayer in the presence of agar. The PFU developed were scored
at 24 h pi. PR values were calculated relative to the PFU recovered in cells transfected
with PRSV/L (0:1). (C) Virus titers recovered from supernatants of transfected cells, as in
A, at 4 h pi with FMDV (MOI of about 1).VSV, indicating that a non FMDV-speciﬁc mechanism/s is involved
in this inhibitory effect.
Single cells transiently expressing 3AB proteins show a decreased level of
FMDV infection
To determine whether transient expression of 3A, 3AB1, 3AB1B2 or
3AB1B2B3 affected also the levels of FMDV protein synthesis in
infected cells, the percentage of BHK-21 cells exhibiting VP1
ﬂuorescence in infected monolayers was determined. Under the
infection conditions used (MOI of 10), about 50% of the control cells
transfected with pRSV/L were positive for VP1, while this percentage
was reduced in cells expressing 3AB proteins (Fig. 7A) that ranged
from 40% (3AB1) to 25% (3AB1B2B3). Similar reductions in cells
positive for glycoprotein G ﬂuorescence were observed upon
infection of transfected cells with VSV (Fig. 7A). Double immuno-
ﬂuorescence assays indicated that a majority of cells showing intense
green ﬂuorescence to 3A did not exhibit red ﬂuorescence to either
FMDV VP1 or VSV G proteins. In VSV infected cells, a quantitative
analysis was possible, as expression of 3A or 3A(B) products could
only be due to plasmid transfection. The results obtained indicated
that ﬂuorescence to VSV G protein was detected in less than 1% of
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Thus, immunoﬂuorescence detection of 3A/3A(B) proteins correlated
with a lack of progress of VSV and FMDV infection.
Inverse correlation between transient expression level of proteins from
the 3AB region and decrease of FMDV multiplication
To address whether the expression level of 3A(B) proteins in
transfected cells inﬂuenced the extent of decrease of FMDV
multiplication, BHK-21 cells were transfected with different ratios
of pRSV/3AB1B2B3 to pRSV/L. As shown in Fig. 8A, decreasing ratios
(1:1 to 1:8) of pRSV/3AB1B2B3 resulted in the expression of lower
amounts of 3AB1B2B3 protein. The level of 3AB1B2B3 protein
detection correlated with a decreasing trend in the PR observed
upon FMDV infection of transfected cells (Fig. 8B), as well as with an
increase in the virus yield recovered at 4 h pi (Fig. 8C). A similar
trend was observed in the virus yield recovered at 6 and 8 h pi (data
not shown). Thus, these results support a direct dose-effect of the
inhibition exerted by the transient expression of 3AB1B2B3 protein.
Discussion
Here, we report the characterization of stable BHK-21 clones that
express FMDV 3A, 3AB1 and 3AB1B2B3 proteins. To our knowledge, this
is the ﬁrst description among picornaviruses of selection of viable cells
stably expressing proteins from this viral genomic region. The clones
generated in this work provide a useful tool to study the role of
proteins from the 3AB region in FMDV replication and its interaction
with host cell components. The percentage of 3A or 3A(B) clones that
were efﬁciently expanded to yield a monolayer (around 60%) was
lower than that of control Pur and Luc clones, and appeared associated
with low, but detectable, levels of protein expression. These results
demonstrate that low levels of expression of these proteins are
compatible with cell viability. No major cell rearrangements were
found in clones stably expressing 3A, 3AB1 and 3AB1B2B3 (Fig. 1C),
although the increase in lysosomes and residual vesicles observed in
the EM images of cells from clone 3AB1B2B3209 (Fig. 1C), suggests that
expression of these proteins could exert a certain level of toxicity. In
addition, no evidence of alterations in the distribution of gp74 protein,
a cis-Golgi marker whose pattern results relocated upon FMDV
infection (Garcia-Briones et al., 2006), of the ER marker calreticulin
and of the patterns of actin ﬁbers and microtubules were observed in
the 3A/3A(B) clones.
The low levels of 3A/3A(B) protein expression detected speciﬁcally
enhanced viral yield, and plaque formation as well, upon FMDV
infection. In addition, enhancement of both the amount of VP1 capsid
protein and the percentage of cells expressing detectable levels of this
protein was observed. The increase in virus yield was speciﬁc for
FMDV, as it was not observed in clones infected with the related
picornavirus EMCV or with VSV, an unrelated rhabdovirus, whose PFU
were similar in number and size to those developed by control clones.
These results suggest that blocking of unspeciﬁc anti-viral mechan-
isms, such us interferon (Chinsangaram et al., 1999; Thacore, 1978), do
not play a relevant role in the increase of FMDV replication. On the
other hand, the low dispersion of the FMDV titers among control
clones (Luc and Pur) and its similarity to that of uncloned BHK-21 cells,
points against: i) selection of pre-existing BHK-21 cells with a lower
FMDV susceptibility, and ii) the decreased susceptibility being the
result of an adaptation to the clonal selection itself.
A trend towards detection of lower amounts of 3A/3A(B) products
in clones supporting higher levels of FMDVmultiplicationwas noticed.
Thus, one of the clones, 3AB1B2B3209, that showed a higher
susceptibility to FMDV infection, expressed a low level of 3AB1B2B3
protein (see Figs. 1A, 2A and 3). Indeed, transfection of clone
3AB1B2B3209 with pRSV/3AB1B2B3, resulted in a 14% reduction of
the PI determined upon FMDV infection (data not shown), indicatingthat the enhancement of viral multiplication was, partially reversible
and that this reversionwas likely be due to a higher expression level of
the 3A(B) protein. These results suggest that, in the absence of major
cell rearrangements, low levels of 3AB proteins expressed in trans can
speciﬁcally stimulate FMDV multiplication in BHK-21 cells. This effect
could be mediated by alterations of cell components not detected in
our analyses and/or by an enhancement of virus replication due to
the presence in infected cells of pre-existing levels of 3A/3A(B)
proteins. On the other hand, the effect of these proteins on viral yield
only occurs when present intracellularly prior to virus infection (Figs.
5A, B).
In picornavirus infected cells translation of the viral message that
depends on an internal ribosome entry site (IRES)-mediated mechan-
ism (Martínez-Salas et al., 2008) is the ﬁrst intracellular event, and
therefore precedes viral RNA replication (Belsham andMartínez-Salas,
2004). A potential role of 3A protein in viral RNA translation was
discarded by the lack of effect on FMDV-IRES dependent translation in
any of the clones analyzed (Fig. 5C). Uridylylated 3B is required to
initiate picornavirus RNA synthesis (Andino et al., 1993; Lyle et al.,
2002; Towner et al., 1996) and for FMDV, the three 3B copies can be
uridylylated in vitro (Nayak et al., 2005). Assuming that 3A(B) proteins
expressed in trans can be uridylylated in the context of FMDV
infection, the availability of 3B precursor in the 3AB1 and 3AB1B2B3
clones could contribute to the increase in FMDV replication. However,
clones expressing 3A alone also showed similar levels of FMDV
multiplication increase. In other picornaviruses the 3AB protein can be
involved in both cis and trans acting functions. In PV, while P3
precursor, but not 3AB protein, can complement in trans RNA
replication-defective mutants in 3A in a cell-free translation/replica-
tion assay (Towner et al., 1998), complementation of a 3B uridylyla-
tion-deﬁcient mutant has been reported when 3AB, but not 3B or 3BC,
was provided in trans using a dicistronic system in HeLa cells (Cao and
Wimmer, 1995; Liu et al., 2007). Also, the growth of hepatitis A virus
mutants with an impaired 3AB/3ABC processing can be enhanced by
co-expressing 3AB or 3ABC (Kusov and Gauss-Muller, 1999). Likewise
mutations in PV 3A protein producing decrease in virus yield do not
affect translation, polyprotein processing, uridylylation of VPg or
synthesis of negative-strand RNA, but markedly reduces positive-
strand RNA synthesis (Teterina et al., 2003). Concerning FMDV 3A and
3A(B), further work is required to understand the mechanism
underlying the increase in susceptibility promoted by the low levels
of expression of these proteins to subsequent infection.
A different effect on virus multiplication was found in cells
transiently expressing proteins from the 3AB region at levels that
were, in average, seven-fold higher than those found in 3A/3A(B)
clones, in spite of only about 20% of transfected cells showing
detectable ﬂuorescence to 3A. Under these high expression condi-
tions, and as reported for PV replication (Egger et al., 2000), a non-
speciﬁc inhibitory effect on FMDV yield was observed. Thus, the PFU
and virus yield recovered upon FMDV infection were lower than in
control transfected cells. The inhibition exerted by 3A/3A(B)
transient expression affected, to a similar extent, the growth of
EMCV and VSV. For both viruses, the number but not the size, of the
PFU recovered upon infection was shown to be reduced, suggesting
that the virus blockage induced by 3A/3A(B) mostly affects early
steps of virus infection and that, once a cell becomes infected, the
virus growth is similar to that of control cells. Consistently,
quantitative analysis of infected cells expressing VP1 or G protein
indicated that a majority of cells exhibiting high levels of 3A/3A(B)
transient expression did not result productively infected by either
FMDV or VSV, at times in which most of the control cells did. This
inhibitory effect would become bypassed by the high amount of
virus produced by non-transfected cells. A lack of type I IFN
receptors and/or of functional effector pathways for these molecules
has been reported for BHK-21 cells (Chinsangaram et al., 1999; Lam
et al., 2005). Indeed, growth of BHK-21 cells in acid-treated culture
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al., 1999) did not affect PFU recovery upon subsequent infection
with FMDV or VSV (data not shown). Thus, induction of type I
interferon is not likely involved in the viral inhibition observed in
transfected cells.
The stable clones generated in this work provide a tool to
investigate the mechanism underlying the effect in susceptibility to
FMDV infection induced in trans by different levels of expression of
proteins from the 3AB region. Taken together, the results shown
here indicate that 3A enhancing effect observed in transformed
clones is independent of cell membranes rearrangements, it is
unrelated to a factor release to the extracellular medium, and it
appears to operate at a virus multiplication step posterior to the
ﬁrst rounds of viral RNA translation.
Materials and methods
Cells, viruses, antibodies and proteins
BHK-21 cells were grown as described (Sobrino et al., 1983).
Viruses FMDV C-S8c1 (Sobrino et al., 1983), EMCV, kindly provided
by L. Carrasco (CBMSO, Spain), and VSV, Indiana isolate (Novella et
al., 1996), were grown and titrated as previously described (Rosas et
al., 2003). The following antibodies to FMDV proteins were used:
MAb SD6 to VP1 (Mateu et al., 1987), MAb 2C2 to 3A and 1F8 to 3B
(De Diego et al., 1997) and polyclonal serum 163, produced by rabbit
immunization with three consecutive injections of 3A recombinant
protein (R. Armas, unpublished results). MAb I1 was used to detect
VSV glycoprotein G (Lefrancois and Lyles, 1982); cell protein markers
were detected using MAb AC-74 to β-actin (Sigma), MAb CC92 to
the cis-Golgi network protein gp74 (Alcalde et al., 1994), rabbit
polyclonal serum to the ER marker calreticulin (Abacam) and to βII-
tubulin (Armas-Portela et al., 1999), and Alexa Fluor 488-labelled
phalloidin (Molecular Probes). Horse radish peroxidase (HRP)-
conjugated protein A (Sigma), HRP-conjugated rabbit anti-mouse
IgG and horse anti-rabbit IgG (Amersham), and goat anti-mouse or
anti-rabbit IgG coupled to Alexa Fluor 594 or 488 (Molecular
Probes) were used as secondary antibodies. A C-S8c1 FMDV 3A
protein expressed from the pRSET vector (Núñez et al, unpublished
results) and puriﬁed trough a Ni-NTA Agarose (Qiagen) column
(Hata et al., 2000) was used to asses its effect on the susceptibility
of BHK-21 cells to FMDV infection.
Stable cell transformation and transient expression of FMDV proteins
cDNAs spanning FMDV 3A, 3AB1 or 3AB1B2B3C coding region
(Toja et al., 1999) were used to replace the luciferase gene in
plasmid pRSV/L (de Wet et al., 1987) downstream of the Rous
Sarcoma Virus (RSV) LTR promoter, as described (Garcia-Briones et
al., 2006). For stable cell transformation, plasmids (5 μg) were co-
transfected with pBSpacΔp (pPur) (de la Luna et al., 1988) at a molar
ratio of 3:1 in BHK-21 cells (60 mm Ø dish), as previously described
(Rosas et al., 2003). Plasmid pPur encodes puromycin acetyl-
transferase, conferring resistance to puromycin. Cells resistant to
puromycin (purR) (10 μg/ml) were selected, and independent purR
clones, obtained by limiting dilution, were expanded in the
presence of puromycin (2.5 μg/ml), to avoid loss of integrated
DNAs (de la Luna and Ortin, 1992). Cell stocks were kept frozen in
liquid N2 for further analysis. All the PurR clones were stable,
keeping the expression of the corresponding FMDV genes for, at
least 10 serial passages, including more than 4 freezing and thawing
cycles.
For transient expression assays, BHK-21 cells were transfected
with pRSV derivatives expressing 3A, 3AB1, 3AB1B2 or 3AB1B2B3
using lipofectamine plus (GIBCO, BRL), as described (Garcia-Briones
et al., 2006).Ampliﬁcation and sequencing of FMDV RNA
Cell monolayers (about 4 x 106 cells), were lysed and the
cytoplasmic RNA extracted, incubated with DNase RQ1 and RT-PCR
ampliﬁed, as described (Rosas et al., 2003). Sequencing of 3A(B) RNA
from positive clones was performed from ampliﬁed cDNAs, as
reported (Baranowski et al., 2003) and conﬁrmed the integrity of
the corresponding FMDV transgene.
Virus yield assay
To assess the capacity of FMDV to grow in BHK-21 cells expressing
FMDV 3A/3A(B) proteins, triplicates (about 5x106 cells, 60mmØplate)
of monolayers at 16 h post-transfection (pt) or stably transformed
clones cells were infected with FMDV C-S8c1 at a multiplicity of
infection (MOI) — expressed as plaque forming units (PFU)/cell – of 1.
After 1 h of adsorption, infection was allowed to proceed in DMEM
supplemented with 4% FBS. Supernatant samples withdrawn at
different times post-infection (pi) were used to estimate the viral
titer (PFU/ml) on BHK-21 cells for transient expressions, or on Pur104
clone cells for stably transformed cells, as described (Bigeriego et al.,
1999; Gutierrez et al., 1994). Results are the mean from three
independent titer determinations.
Viral plaque assay
Determination of virus yield was performed as described (Gutier-
rez et al., 1993). Brieﬂy, monolayers (about 5x106 cells, 60 mmØ plate)
transiently transfected (16 h pt) or stably transformed cells were
infected with FMDV (about 50 PFU), EMCV or VSV (about 100 PFU). At
24 h pi, cells were ﬁxed and stained to determine the PFU developed.
The percentage of virus yield reduction (PR) or virus yield increase (PI)
was calculated as (PFU control – PFU) x 100 / PFU control, or as (PFU –
PFU control) x 100 / PFU control, respectively, using the mean of three
independent plaque assays. Cells transfectedwith pRSV/L for transient
expression, or the average of four clones transformed with pPur alone
for stably transformed cells were used as the control of PFU.
Protein detection
For western-blot, extracts were prepared from cell monolayers
(35 mm Ø), proteins resolved on a 12% SDS-PAGE, transferred onto a
nitrocellulose membrane and incubated with MAb 2C2 targeted to
FMDV 3A (Garcia-Briones et al., 2006). Membranes were incubated
with HRP-coupled anti-mouse antibody and proteins subsequently
detected using an ECL kit (Amersham). A Typhoon equipment and
software ImageQuant TL (Amersham) were used for quantiﬁcation of
the intensity of protein. For detection of intracellular virus by
immunoﬂuorescence, infected monolayers were processed as
described (Garcia-Briones et al., 2006), using rabbit serum 163 to
3A, and MAbs SD6 and I1 to FMDV VP1 and VSV G proteins,
respectively. Anti-rabbit or anti-mouse IgG coupled with Alexa Fluor
488 or 594 was used as secondary antibody.
Electron microscopy
Cells were grown on 100 mm Ø dishes, washed with PBS and ﬁxed
for 30 min in 1% glutaraldehyde, 4% paraformaldehyde in 0.1 M
phosphate buffer pH 7.4 at room temperature, for 1 h. Then, cells were
scrapped in 1 ml of 0.1 M phosphate buffer, 0.5% bovine serum
albumin, postﬁxed in 1% osmium tetroxide plus potassium ferrocia-
nure for 1 h at 4 oC. After three washes with double distilled water,
cells were treated with 0.15% tanic acid in phosphate buffer pH 7.4 for
1 min, washed againwith buffer and twice with double distilled water
prior the staining with 2% uranyl acetate for 1 h at room temperature.
After three washes with double distilled water the samples were
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TAAB 812 resin (TAAB lab. Bershire, England). Cell samples were
examined using a JEM-1010 electron microscope (Jeol, Japan) and
images were acquired using a digital camera Bioscan 792 (Gatan, Inc
5933 Coronado Lane. Pleasanton, CA 94588).
Analysis of 3A protein release to the growth medium
Supernatant samples (10 ml) were withdrawn from monolayers
(about 2x107 cells, 100 mm Ø plate) of either BHK-21 cells transiently
expressing FMDV 3A or 3AB1B2B3 protein (16 h pt), or from stably
transformed clones. Samples were supplemented with 1 mM PMSF
and protease inhibitor cocktail (Roche), dialyzed at 4 °C for 24 h
against 20 mM Tris-HCl buffer, pH 7.4 (with changes every 8 h) and
concentrated by freeze-drying until total dry up, for 24 h at -80°C and
0,07 mbar using a Virtis Sentry device. The samples were resuspended
in Laemmli buffer and analyzed by western blot.
IRES-dependent translation activity
Bicistronic constructs (CMVpBIC) encompassing the FMDV IRES
between the chloramphenicol acetyl transferase (CAT) and luciferase
gene subcloned in pCDNA3 to generate transcripts from the CMV
promoter, were transfected in stably transformed cells expressing 3A
or 3AB1B2B3 proteins; as a control, Pur clones were transfected in
parallel. Transfection of 80–90% conﬂuent monolayers with CMVpBIC
bicistronic plasmid was carried out using cationic liposomes as
previously described (Lopez de Quinto et al., 2002). Extracts from 2
x 105 cells were prepared 20 h after transfection in 100 μl of 50 mM
Tris–HCl, pH 7.8, 120 mM NaCl, 0.5% NP-40. Luciferase and CAT
activities were measured as described (Martinez-Salas et al., 1993).
Assays were performed at least two times.
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